Last reviewed · How we verify
Golytely — Competitive Intelligence Brief
marketed
sodium bicarbonate
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Golytely (Sodium Bicarbonate) — Abbott. Golytely works by neutralizing stomach acid and helping to protect the stomach lining.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Golytely TARGET | Sodium Bicarbonate | Abbott | marketed | sodium bicarbonate | 1981-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (sodium bicarbonate class)
- Abbott · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Golytely CI watch — RSS
- Golytely CI watch — Atom
- Golytely CI watch — JSON
- Golytely alone — RSS
- Whole sodium bicarbonate class — RSS
Cite this brief
Drug Landscape (2026). Golytely — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-bicarbonate. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab